Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis

被引:159
作者
Mizuhara, H
Uno, M
Seki, N
Yamashita, M
Yamaoka, M
Ogawa, T
Kaneda, K
Fujii, T
Senoh, H
Fujiwara, H
机构
[1] OSAKA UNIV,SCH MED,CTR BIOMED RES,SUITA,OSAKA 565,JAPAN
[2] FUJISAWA PHARMACEUT CO LTD,NEW DRUG RES LABS,KASHIMA YODOGAWA,JAPAN
[3] FUJISAWA PHARMACEUT CO LTD,PHARMACOL RES LABS,KASHIMA YODOGAWA,JAPAN
[4] OSAKA CITY UNIV,SCH MED,DEPT ANAT 2,OSAKA 545,JAPAN
关键词
D O I
10.1053/jhep.1996.v23.pm0008675184
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A single intravenous injection of concanavalin A (Con A) induces T-cell activation and an acute hepatitis in mice. This study investigated the role of interferon gamma (IFN-gamma) in the pathogenesis of this hepatitis model. Striking increases in the plasma levels of various cytokines, including tumor necrosis factor (TNF), interleukin-2 (IL-2), and IFN-gamma, were detected before the increase in plasma aminotransferase levels induced by Con A injection. TNF levels peaked within 2 hours, whereas IFN-gamma levels peaked at 6 hours after Con A injection. In contrast to a sharp peak of TNF levels, high IFN-gamma levels were detected for a more prolonged period. Passive immunization with anti-IFN-gamma monoclonal antibody (MAb) conferred a dose-dependent protection against liver injury in this model. This protection was observed when anti-IFN-gamma MAb was administered at least 30 minutes before Con A injection but not when given 1 hour after Con A injection. The protection from Con A-induced hepatitis was also induced by administration of rIL-6 before Con A injection. rIL-6 treatment induced significant albeit incomplete inhibition of IFN-gamma and TNF production, whereas this regimen did not affect IL-2 production. Despite striking protective effects of rIL-6 or anti-IFN-gamma MAb, comparable levels of cellular (both T cell and polymorphonuclear cell) infiltration were detected in liver sections from animals untreated, or treated with either rIL-6 or anti-IFN-gamma MAb. Moreover, electron microscopic examination showed that infiltrating T cells exhibited a blastoid appearance in all groups. These results indicate that IFN-gamma plays a critical role in the development of Con A-induced acute hepatitis and suggest that IL-6 administration can regulate the manifestation of hepatitis through mechanisms including the reduced production of inflammatory cytokines such as IFN-gamma.
引用
收藏
页码:1608 / 1615
页数:8
相关论文
共 34 条
[1]  
ADERKA D, 1989, J IMMUNOL, V143, P3517
[2]   MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[3]  
BRUNDA MJ, 1994, J LEUKOCYTE BIOL, V55, P280
[4]   ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS [J].
BRUNDA, MJ ;
LUISTRO, L ;
WARRIER, RR ;
WRIGHT, RB ;
HUBBARD, BR ;
MURPHY, M ;
WOLF, SF ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1223-1230
[5]  
CELADA A, 1991, J IMMUNOL, V146, P114
[6]   THE ROLE OF CACHECTIN/TNF IN ENDOTOXIC-SHOCK AND CACHEXIA [J].
CERAMI, A ;
BEUTLER, B .
IMMUNOLOGY TODAY, 1988, 9 (01) :28-31
[7]   INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[8]   INTERFERON - A CYTOTOXIC LYMPHOCYTE-T DIFFERENTIATION SIGNAL [J].
CHEN, LK ;
TOURVIEILLE, B ;
BURNS, GF ;
BACH, FH ;
MATHIEUMAHUL, D ;
SASPORTES, M ;
BENSUSSAN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (07) :767-770
[9]   GAMMA-INTERFERON ENHANCES MACROPHAGE TRANSCRIPTION OF THE TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, AND UROKINASE GENES, WHICH ARE CONTROLLED BY SHORT-LIVED REPRESSORS [J].
COLLART, MA ;
BELIN, D ;
VASSALLI, JD ;
DEKOSSODO, S ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (06) :2113-2118
[10]   GALACTOSAMINE HEPATITIS - KEY ROLE OF THE NUCLEOTIDE DEFICIENCY PERIOD IN THE PATHOGENESIS OF CELL INJURY AND CELL-DEATH [J].
DECKER, K ;
KEPPLER, D .
REVIEWS OF PHYSIOLOGY BIOCHEMISTRY AND PHARMACOLOGY, 1974, 71 :77-106